Stay updated on Daratumumab Combo in MRD+ Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Combo in MRD+ Myeloma Clinical Trial page.

Latest updates to the Daratumumab Combo in MRD+ Myeloma Clinical Trial page
- Check3 days agoChange DetectedRemoved “Multiple myeloma” related-topic links (including MedlinePlus Genetics).SummaryDifference0.1%

- Check10 days agoChange DetectedOn 2026-04-13, the record was updated with new topics (Multiple myeloma) and locations (Novant Health Charlotte, Tennessee Oncology Chattanooga, Texas Oncology P A 1) and related link (MedlinePlus Genetics); earlier sites (Novant Health, Tennessee Oncology, Texas Oncology P A) were removed, and revision updated to v3.5.2.SummaryDifference0.3%

- Check18 days agoChange DetectedRemoved the condition 'Multiple Myeloma' and the related topic 'MedlinePlus Genetics' from the study page.SummaryDifference0.1%

- Check32 days agoChange DetectedAdded related topic 'Multiple myeloma' and a link to MedlinePlus Genetics. Updated page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check39 days agoChange DetectedAdministrative date updates were added to the study record, reflecting recent edits and posting times but not altering the study details.SummaryDifference0.2%

- Check47 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Daratumumab Combo in MRD+ Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in MRD+ Myeloma Clinical Trial page.